DCMM
DG Capital Management (Massachusetts) Portfolio holdings
AUM
$102M
1-Year Return
29.14%
This Quarter Return
-6.06%
1 Year Return
+29.14%
3 Year Return
+96.76%
5 Year Return
–
10 Year Return
–
AUM
$148M
AUM Growth
-$17.5M
(-11%)
Cap. Flow
-$4.8M
Cap. Flow
% of AUM
-3.23%
Top 10 Holdings %
Top 10 Hldgs %
32.85%
Holding
81
New
16
Increased
25
Reduced
25
Closed
15
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$3.05M |
| 2 |
Intuitive Surgical
ISRG
|
$2.19M |
| 3 |
TJX Companies
TJX
|
$2.19M |
| 4 |
Trip.com Group
TCOM
|
$2.05M |
| 5 |
Amazon
AMZN
|
$2.02M |
Top Sells
| 1 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$3.28M |
| 2 |
PARA
Paramount Global Class B
PARA
|
$2.8M |
| 3 |
MON
Monsanto Co
MON
|
$2.39M |
| 4 |
Biogen
BIIB
|
$2.36M |
| 5 |
NXP Semiconductors
NXPI
|
$2.35M |
Sector Composition
| 1 | Healthcare | 40.2% |
| 2 | Financials | 15.79% |
| 3 | Consumer Discretionary | 15.09% |
| 4 | Technology | 8.11% |
| 5 | Communication Services | 6.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Eli Lilly
LLY
$646B
| $5.85M | 3.94% |
69,950
-7,485
| -10% | -$626K |
|
2
Adobe
ADBE
$150B
| $5.49M | 3.7% |
66,814
+18,875
| +39% | +$1.55M |
|
|
3
Amazon
AMZN
$2.52T
| $5.33M | 3.59% |
208,200
+79,100
| +61% | +$2.02M |
|
4
Gilead Sciences
GILD
$143B
| $5.04M | 3.39% |
51,285
+12,885
| +34% | +$1.27M |
|
5
Nike
NKE
$110B
| $5.03M | 3.39% |
81,814
+5,272
| +7% | +$324K |
|
6
Amgen
AMGN
$151B
| $4.94M | 3.32% |
35,685
+5,400
| +18% | +$747K |
|
7
Visa
V
$667B
| $4.87M | 3.28% |
69,858
-797
| -1% | -$55.5K |
|
8
Mastercard
MA
$531B
| $4.82M | 3.25% |
53,460
+8,115
| +18% | +$731K |
|
9
Novartis
NVS
$249B
| $3.75M | 2.53% |
45,544
-296
| -0.6% | -$24.4K |
|
|
AGN
10
DELISTED
Allergan plc
AGN
| $3.67M | 2.47% |
13,483
+2,595
| +24% | +$705K |
|
11
AbbVie
ABBV
$369B
| $3.56M | 2.4% |
65,375
+2,725
| +4% | +$148K |
|
12
Meta Platforms (Facebook)
META
$1.91T
| $3.49M | 2.35% |
38,768
+5,290
| +16% | +$476K |
|
|
13
Biogen
BIIB
$20.9B
| $3.45M | 2.32% |
11,804
-8,070
| -41% | -$2.36M |
|
14
Alphabet (Google) Class C
GOOG
$2.85T
| $3.32M | 2.24% |
106,520
+37,300
| +54% | +$1.16M |
|
15
Bristol-Myers Squibb
BMY
$94.3B
| $3.06M | 2.06% |
51,695
-12,210
| -19% | -$723K |
|
|
16
SPDR S&P 500 ETF Trust
SPY
$661B
| $3.05M | 2.05% |
+15,915
| New | +$3.05M |
|
17
Goldman Sachs
GS
$223B
| $2.98M | 2.01% |
17,175
-890
| -5% | -$155K |
|
18
Starbucks
SBUX
$95.4B
| $2.81M | 1.9% |
49,509
+22,979
| +87% | +$1.31M |
|
19
BioMarin Pharmaceuticals
BMRN
$10.7B
| $2.75M | 1.85% |
26,130
+1,785
| +7% | +$188K |
|
20
Bausch Health
BHC
$2.69B
| $2.75M | 1.85% |
15,395
+2,775
| +22% | +$495K |
|
21
HDFC Bank
HDB
$181B
| $2.73M | 1.84% |
89,384
+15,710
| +21% | +$480K |
|
22
Delta Air Lines
DAL
$39.7B
| $2.55M | 1.72% |
56,890
+1,080
| +2% | +$48.5K |
|
23
Jazz Pharmaceuticals
JAZZ
$7.83B
| $2.54M | 1.71% |
19,132
+4,001
| +26% | +$531K |
|
24
Morgan Stanley
MS
$236B
| $2.54M | 1.71% |
80,570
+9,880
| +14% | +$311K |
|
25
AB InBev
BUD
$116B
| $2.53M | 1.7% |
23,765
+4,050
| +21% | +$431K |
|